Sympathetic Nervous System Overactivity in Hypertensive Patients with Chronic Renal Failure - Role of Upright Body Position

References

• Smith HW. Chapter XIV. The control of the renal circulation and the action of pharmacodynamic agents. In: Smith HW, ed. The kidney. Structure, and function in health and disease. New York: Oxford University Press; 1951. p. 411–60.
   Google Scholar
• Molzahn M, Dissmann TH, Halim S, Lohmann FW, Oelkers W. Orthostatic changes of hemodynamics, renal function, plasma catecholamines and plasma renin concentration in normal and hypertensive man. Clin Sci 1972; 42: 209–22.
   Google Scholar
• Shipley RE, Study RS. Changes in renal blood flow, extraction of insulin, glomerular filtration rate, tissue pressure and urine flow with acute alterations of renal artery blood pressure. Am J Physiol 1951; 167: 676–88.
   PubMed Web of Science ®Google Scholar
• Dworkin LD, Ichikawa I, Brenner B. Hormonal modula-tion of glomerular function. Am J Physiol 1983; 244: F95–F104.
   Google Scholar
• Levitan D, Massry SG, Romoff M, Campese VM. Plasma catecholamines and autonomic nervous system function in patients with early renal insufficiency and hypertension: effect of clonidin. Nephron 1984; 36: 24–9.
   PubMed Web of Science ®Google Scholar
• Fiorica V, Kem DC. Plasma norepinephrine, blood pressure and heart rate response to graded change in body position. Aviat Space Environ Med 1985; 56: 1166–71.
   PubMedGoogle Scholar
• Hollister AS, Tanaka I, Imada T, Onrot J, Biaggioni I, Robertson D, Inagami T. Sodium loading and posture modulate human atrial natriuretic factor plasma levels. Hypertension 1986; 8 (Suppl II): II-106-II–111.
   Google Scholar
• Solomon LR, Atherton JC, Bobinski H, Green R. Effect of posture on plasma immunoreactive atrial natriuretic peptide concentrations in man. Clin Sci 1986; 71: 299–305.
   PubMed Web of Science ®Google Scholar
• Laragh JH. Atrial natriuretic hormone: a regulator of blood pressure and volume homeostasis. Kidney Int 1988 (Suppl) 25: S64–S71.
   Google Scholar
• Shenker Y, Port FK, Swartz RD, Gross MD, Grekin RJ. Atrial natriuretic hormone secretion in patients with renal failure. Life Sci 1987; 41: 1635–44.
   Google Scholar
• Hirata Y, Ishii M, Fukui K, Hayakawa H, Sugimoto T, Matsuoka H, Sugimoto T, Kangawa K, Matsuo H. Interaction between sympathetic nerve activity and atrial natriuretic peptide with respect to the effects on renalhemodynamics in patients with cardiovascular disease. Jpn Circ J 1989; 53: 446–52.
   Google Scholar
• Svarstad E, Iversen BM, Ofstad J. Extended measure-ments of glomerular filtration rate and effectiv renal plasma flow in ambulatory patients. Scand J Urol Nephrol 1995; 29: 375–82.
   Google Scholar
• Mo R, Myking OL, Lund-Johansen P, Omvik P. The Bergen Blood Pressure Study: inappropriately low levels of circulating atrial natriuretic peptide in offspring of hypertensive families. Blood Press 1994; 3: 223–30.
   Google Scholar
• Ghione S, Palombo C, Pellegrini M, Fommei E, Pilo A, Donato L. The kinetics of plasma noradrenaline in normal and hypertensive subjects. Clin Sci Mol Med 1978; 55: 89s–92s.
   Google Scholar
• Laederach K, Weidmann P. Plasma and urinary catecho-lamines as related to renal function in man. Kidney Int 1987; 31: 107–11.
   PubMed Web of Science ®Google Scholar
• Masuyama Y, Nishimura T,Nishio I, Kuchii M. Nora-drenaline clearance in hypertensive patients with various degrees of renal function. Clin Sci 1979; 57: 213s–15s.
   Google Scholar
• Link L, Weidmann P, Beretta-Piccoli C, Boehringer K, Schiffi H, Reubi FC. Renal clearance of catecholamines in man. Kidney Int 1982; 21: 902 (abstract).
   Google Scholar
• Pauletto P, Scannapieco G, Pessina AC. Sympathetic drive and vascular damage in hypertension and athero-sclerosis. Hypertension 1991; 17 (Suppl 4): III 75-III 81.
   Google Scholar
• Converse RL, Jacobsen TN, Toto RD, Jost CMT, Consentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327: 1912–18.
   Google Scholar
• Ligtenberg G, Blankestijn PJ, Oey PL, Klein IHH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999; 340: 1321–8.
   Google Scholar
• Remuzzi G. Sympathetic overactivity in hypertensive patients with chronic renal disease. N Engl J Med 1999; 340: 1360–1.
   PubMed Web of Science ®Google Scholar
• Amann K, Rump LC, Simonaviciene A, Oberhauser V, Wessels S, Orth SR, Gross ML, Koch A, Bielenberg GW, Van Kats JP, Ehmke H, Mall G, Ritz E. Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J Am Soc Nephrol 2000; 11: 1469–78.
   Google Scholar
• Bergstrøm J, Alvestrand A, Bucht H, Gutierrez A. Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clin Nephrol 1986; 25: 1–6.
   Google Scholar
• Riddervold F, Forslund T, Endresen K, Simonsen S, Talseth T, Fyhrquist F. Hormonal changes during tilt and atrial pacing in heart transplant patients. Transplant Proc 1990; 22: 191–4.
   PubMed Web of Science ®Google Scholar
• Suda S, Weidmann P, Saxenhofer H, Cottier C, Shaw SG, Ferrier C. Atrial natriuretic factor in mild to moderate chronic renal failure. Hypertension 1988; 11: 483–90.
   PubMed Web of Science ®Google Scholar
• Predel HG, Kipnowski J, Meyer-Lehnert H, Arent R1\4, Kramer HJ. Human atrial natriuretic peptide in non-dialyzed patients with chronic renal failure. Clin Nephrol 1989; 31: 150–5.
   Google Scholar
• Wilkins MR, Wood JA, Adu D, Lote CJ, Kendall MJ, Michael J. Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis. Clin Sci 1986; 71: 157–60.
   Web of Science ®Google Scholar
• Montorsi P, Tonolo G, PoIonia J, Hepburn D, Richards AM. Correlates of plasma atrial natriuretic factor in health and hypertension. Hypertension 1987; 10: 570–6.
   PubMed Web of Science ®Google Scholar
• Sagnella GA, Shore AC, Markandu ND, MacGregor GA. Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet 1986; i: 179–81.
   Google Scholar
• Weselcouch EO, Humphrey WR, Alken JW. Effect of pulmonary and renal circulations on activity of atrial natriuretic factor. Am J Physiol 1985; 249: R595—R602.
   Google Scholar
• Galles AH, Crozier IG, Nicholls MG, Espiner EA, Yandle TG. Effect of posture on clearance of atrial natriuretic peptide from plasma. J Clin Endocrinol Metab 1987; 65: 1095–7.
   Google Scholar
• Hirsch AT, Creager MA, Dzau VJ. Relation of atrial natriuretic factor to vasoconstrictor hormones and regional blood flow in congestive heart failure. Am J Cardiol 1989; 63: 211–16.
   Google Scholar
• Oie BK, Myking OL, Hoff PI, Ohm 0J. The acute effects of induced tachycardia on coronary sinus and arterial plasma levels of atrial natriuretic peptide and on arterial catecholamines. Scand J Clin Lab Invest 1994; 54: 155–9.
   Google Scholar
• Uehlinger DE, Weidmann P, Gnalinger MP, Shaw S. Lang RE. Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man. J Clin Endocrinol Metab 1986; 63: 669–74.
   Google Scholar
• Iversen B, Ofstad J: Renal blood flow autoregulation in normal and hypertensive kidneys. In: Persson AEG, Boberg U, eds. The juxtaglomerular apparatus. Amster-dam: Elsevier; 1988. p. 419–25.
   Google Scholar
• Weidmann P, Hasler L, Gnalinger MP, Lang RE, Uehlinger DE, Shaw S, Rasher W, Reubi FC. Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest 1986; 77: 734–42.
   PubMed Web of Science ®Google Scholar
• Beasley D, Malvin RL. Atrial extracts increase glomeru-lar filtration rate in vivo. Am J Physiol 1985; 248: F24—F30.
   Google Scholar
• Steinhausen M. Physiology and patophysiology of renal circulation. Z Kardiol 1987; 76 (Suppl 4): 71–9.
   PubMedGoogle Scholar
• Sothem RB, Vesely DL, Kanabrocki EL, Bremner FW, Third IL, McCormick JB, Dawson S, Ryan M, Greco J, Bean JT, Nemchausky BM, Shirazi P, Scheving LE. Circadian relationships between circulating atrial na-triuretic peptides and serum sodium and chloride in healthy humans. Am J Nephrol 1996; 16: 462–70.
   Google Scholar
• Portaluppi F, Vergnani L, degli Uberti EC. Atrial natriuretic peptide and circadian blood pressure regula-tion: clues from a chronobiological approach. Chrono-biol Int 1993; 10: 176–89.
   Google Scholar
• Pocock SJ. Clinical trials. A practical approach. In: Clinical Statistics. New York: John Wiley & Sons; 1983. p. 227–33.
   Google Scholar